
Covid is quiet right now, but doctors are vigilant for a summer rise
National wastewater data shows low Covid-19 activity, according to the Centers for Disease Control and Prevention. The weekly reported Covid-19 deaths in April were slightly down compared with the same time a year earlier, federal data shows. Still, more than 300 Covid-19-related deaths were reported weekly as recently as mid-April.
Some infectious-disease specialists said they expect more cases this summer, as there have been somewhat regular summertime increases in the past. Others cautioned that Covid-19 can still surprise us, more than five years after it spurred a global pandemic that killed more than 1.2 million Americans.
'It is at our lowest levels it has been since the beginning of the pandemic," said Michael Osterholm, director of the Center for Infectious Disease Research and Policy at the University of Minnesota. 'Our challenge is we don't know what that means for tomorrow."
The Trump administration on Tuesday released a more stringent set of guidelines for approving Covid-19 vaccines, requiring randomized controlled trials for new Covid-19 vaccines for many children and adults. The Food and Drug Administration expects it will be able to approve shots for adults older than 64 and other high-risk groups based on antibody testing.
The original Covid-19 shots were tested in large, randomized trials with placebos. The updated vaccines to match newer versions of the virus have been tested with antibody testing to ensure that they triggered an immune response.
As of May 10, the CDC projected that 70% of cases were caused by a version of the virus called LP. 8.1, an offshoot of the Omicron variant, which first appeared in late 2021. It is related to the JN.1 variant, which was the target of last season's booster shots. The LP. 8.1 version has picked up new mutations but hasn't yet led to an increase in cases or hospitalizations.
'Because there are so many people who have been vaccinated and infected, there is a high amount of immunity in the population," said Andrew Pekosz, director of the center for emerging viruses and infectious diseases at Johns Hopkins University. 'I think we're also seeing that as a way to dampen the spread of the virus."
Surveillance and monitoring for changes to the virus is continuing, Pekosz said, but at much lower levels than before, so there is more reliance on modeling to suss out variant spread. Hospitalization and death data remain the most solid.
Covid-related hospitalizations in the U.S. are currently on the decline. There were some 1.3 hospitalizations per 100,000 people during the week ended with April 26, down from a winter peak of 4.2 per 100,000 people for the week ended Jan. 4, CDC data show. That rate is down from last winter, when hospitalization rates peaked at 7.8 per 100,000 people.
Most years, the U.S. has experienced additional Covid-19 waves in late spring or summer, in addition to wintertime surges. Last year, a summertime wave peaked at around the week of Aug. 31, with more than 1,300 deaths reported, CDC data shows.
Write to Brianna Abbott at brianna.abbott@wsj.com
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Time of India
3 hours ago
- Time of India
All about the 'Nimbus' and 'Stratus', the new COVID variants monitored closely by WHO
COVID-19 might not dominate the headlines anymore, but that doesn't mean it has stopped evolving. In fact, behind the scenes, scientists are closely tracking several offshoots of the Omicron variant. Tired of too many ads? go ad free now Two of those, unofficially nicknamed Nimbus and Stratus, are now on the radar for their quick global spread and potential to evade immunity. Here's a closer look at what we know so far. Nimbus (NB.1.8.1) First spotted in early 2025, NB.1.8.1, or 'Nimbus', has made its presence felt quickly. It is currently listed as a 'variant under monitoring' (VUM) by the World Health Organization (WHO), - meaning they may require prioritised attention and tracking by health authorities due to their increased prevalence and potential public health implications. By late April, it had jumped from 2.5% to over 11% of all sequenced COVID-19 cases, especially across parts of Asia and the Western Pacific. Further, as per TODAY, 43% of cases in the U.S. are driven by this variant. Nimbus is part of the Omicron family, and it's a recombinant virus — a mash-up of different viral lineages that combined genetic material. It descends from a complex mix involving XDV, which itself was formed by blending JN.1 and another hybrid known as XDE. Symptoms of Nimbus According to the Global Alliance for Vaccines and Immunizations (Gavi), the symptoms of the NB.1.8.1 variant include: runny nose, headache, fatigue, sneezing, and sore throat. Additionally, people also might feel a razor blade sensation in the throat, which is the defining symptom for this variant, and gastrointestinal symptoms, including: nausea, vomiting, diarrhea, heartburn, bloating, constipation, and stomach pain. Tired of too many ads? go ad free now As of July 9, test positivity is at 3.1%, 0.1% higher than the previous week, according to the . The World Health Organization (WHO), in its May 23 evaluation, stated there's no current evidence that Nimbus is more dangerous than the other Omicron subvariants circulating today. Further, it also states that the currently approved COVID-19 vaccines are still expected to be effective against this variant. Stratus (XFG) First detected in Canada, Stratus (XFG) it's already made significant jumps into Europe and India. By late May, it was behind a quarter of new cases in parts of Europe, overtaking even Nimbus. Stratus, too, has been classified by the WHO as 'Variant under Monitoring'. Stratus is also a recombinant. It formed when two earlier variants, LF.7 and LP.8.1.2, crossed paths and exchanged genetic code. Like most of its Omicron cousins, it spreads quickly, prefers the upper respiratory tract, and seems less likely to lead to severe illness. According to the current available data, symptoms of XFG are similar to those of other Omicron sub-variants which are typically mild upper respiratory symptoms. Symptoms of the XFG People infected with the XFG subvariant have reported a range of symptoms including: chills, shortness of breath, sore throat, fatigue, headache, nausea, vomiting, muscle and body aches, diarrhea, and in some cases, a loss of taste or smell. What sets XFG slightly apart, according to early reports, is one more noticeable symptom: hoarseness. Several individuals have described a rough or raspy voice, which may serve as a subtle clue when trying to distinguish this variant from other circulating strains.


Time of India
3 hours ago
- Time of India
'My son diagnosed with autism and heart attack': Father's chilling testimony on mRNA COVID vaccine
The Senate Homeland Security Committee hears heartbreaking testimonies from victims of alleged mRNA COVID vaccine injuries. A Father, Brian Hooker, revealed his son suffered both a heart attack and was diagnosed with autism after vaccination. The hearing titled "Voices of the Vaccine-Injured" sheds light on stories mainstream media ignored. Watch explosive moments and emotional appeals to lawmakers. Show more Show less

Time of India
6 hours ago
- Time of India
‘Just here to be seen?' Sophie Choudry's cheeky comment on Bollywood at Wimbledon 2025
Trump's Body Raising Red Flags? FIFA World Cup Photos Reveal POTUS' 'DISTURBING' Condition Donald Trump's recent Club World Cup appearance has sparked a frenzy online after viewers noticed his swollen ankles and apparent bruising on his right hand. Is it just poor circulation—or something being covered up? Social media is flooded with theories, from heart issues to hidden medication. With the 2024 election looming, questions about Trump's fitness are once again center stage. We break down the viral photos, public reaction, and what it could really mean for his health. 625 views | 7 hours ago